Making the Case for Reimbursement of Supervised Exercise Therapy in Cancer Care

An interview with Dr. Kathryn Schmitz, Interim Director of the UPMC Hillman Cancer Center.

We have one randomized control trial showing, in one group of cancer patients, that there is a disease free survival benefit and a mortality benefit, and we know that there's a lot of nice to have outcomes, right? Nice, nice to have is quality of life, things that are not going to be something that the payer pays for. So there's our challenge, that's the truth, that's the truth of our situation. That's why it's going to be difficult. And I think the challenge provides us one of the first opportunities to be able to really lay all of that bare. And then the question becomes, how do we motivate hospitals, healthcare systems and payers to pay for something when there is no profit in it for them?
Dr. Kathryn Schmitz

Evidence for exercise as a standard of care in cancer treatment
Improving access to exercise oncology programs
Making the case for reimbursement for exercise oncology programs
CMS coverage of supervised exercise training for people with cancer
Moving Through Cancer areas of focus
Prognosis for 2029

https://www.movetolivemore.com/
https://www.movetolivemore.com/book
https://www.linkedin.com/company/move-to-live-more
@MovetoLiveMore